Guangzhou Baiy | 600332 - Net Income


Guangzhou Baiy reported CNY1.78B in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Aspen Pharmacare ZAR 1.47B 4.94B Dec/2025
Cipla INR 5.55B 1.21B Mar/2026
Dr.Reddys Laboratories INR 2.21B 9.89B Mar/2026
Jiangsu Hengrui CNY 2.28B 322.38M Mar/2026
Kalbe Farma IDR 656.41B 241.76B Sep/2025
Richter Gedeon HUF 65.28B 21.94B Mar/2026
Sh Fosun Pharma CNY 870.83M 23.56M Mar/2026
Sh Pharmaceutical CNY 577.49M 110.71M Dec/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 369M 111M Mar/2026